Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Research Grant Guidelines
The A-T Children’s Project accepts grant applications March 1st and September 1st of each calendar year for up to US$75,000.00 per year for two years.
Post Doctoral Fellowship Award
Find more information on special awards for postdocs who decide to pursue research with the potential to find life-improving therapies for A-T.
Research Grants Funded
Find a list of some of the research grants funded since the A-T Children’s Project’s inception in 1993.
Building on Advancements to Reach a Cure
The A-T Children’s Project provides competitive awards for basic science, translational and clinical research grants related to ataxia-telangiectasia. One and two-year projects are funded up to a maximum total direct cost of $75,000 per year. No administrative overhead or fixed costs are supported.
In giving these grant awards, the Project strives to assist respected scientists in developing a clearer understanding of ataxia-telangiectasia. We are determined to find a timely cure, or life-improving treatments, for this serious disease.
Scientific excellence and relevance to A-T are the paramount criteria used to select supported research projects. Junior investigators, scientists in related disciplines, and individuals with innovative new ideas for A-T research are particularly encouraged to apply for grants, as are laboratories and teams working together from industry as well as teaching universities. Grant award decisions are made through a careful and detailed, two-tiered, peer-review selection process. Grants are reviewed and awarded relatively rapidly so that we are usually able to provide a grant decision within 90 days after receiving a complete proposal from an investigator.
Consistent with the urgency felt by all families impacted by this disease, the A-TCP’s current focus is on funding innovative research strategies that look at A-T in new ways and that include a clear “yes” or “no” answer to the hypotheses rather than merely defining a mechanism. Highest priority is given to projects that, while drawing on basic discoveries, include creative strategies for suggesting and evaluating specific disease-modifying and symptomatic interventions.